Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1327.389
  • -39.880-2.92%
Close Apr 4 16:00 ET
1381.465High1326.645Low
Constituent Stocks: 10Top Rising: SGMO+5.47%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
SGMOSangamo Therapeutics
0.65650.0342+5.50%56.64M36.91M0.76280.62230.76510.5860147.52M143.66M224.71M218.82M-19.94%-24.24%-36.88%-52.08%-20.48%+16.98%-35.64%--25.88%LossLoss28.78%Biotechnology
BLUEbluebird bio
4.9500.060+1.23%218.64K1.06M4.9204.8904.9904.67048.46M48.13M9.79M9.72M+21.32%+26.92%+23.75%-45.12%-49.97%-79.88%-40.65%--2.25%LossLoss6.54%Biotechnology
CRSPCRISPR Therapeutics
32.650-0.010-0.03%3.07M98.85M31.94832.66032.99030.9602.80B2.75B85.77M84.34M-11.73%-20.79%-28.29%-22.11%-28.07%-48.09%-17.05%--3.65%LossLoss6.22%Biotechnology
VRTXVertex Pharmaceuticals
474.620-9.390-1.94%2.88M1.39B484.350484.010499.070473.640121.88B121.50B256.79M255.99M-3.67%-5.68%-2.80%+16.24%-0.32%+16.71%+17.86%--1.13%LossLoss5.25%Biotechnology
CRBUCaribou Biosciences
0.7675-0.0175-2.23%1.01M747.30K0.74110.78500.78400.700871.38M64.42M93.00M83.94M-18.27%-26.20%-33.84%-58.96%-57.36%-82.94%-51.73%--1.20%LossLoss10.60%Biotechnology
NTLAIntellia Therapeutics
6.630-0.260-3.77%4.80M31.88M6.8306.8906.9106.430686.32M649.16M103.52M97.91M-17.84%-26.33%-35.94%-46.83%-62.73%-73.24%-43.14%--4.91%LossLoss6.97%Biotechnology
AAgilent Technologies
103.000-6.670-6.08%3.82M398.84M107.140109.670107.700102.85029.37B29.26B285.10M284.12M-11.54%-14.52%-18.53%-24.88%-27.55%-28.00%-23.17%0.93%1.35%23.6223.254.42%Diagnostics & Research
BEAMBeam Therapeutics
15.270-1.190-7.23%5.49M83.82M15.83016.46016.66514.7201.52B1.31B99.84M85.92M-31.25%-34.46%-46.38%-43.61%-33.70%-45.85%-38.43%--6.39%LossLoss11.82%Biotechnology
EDITEditas Medicine
1.030-0.090-8.04%3.11M3.32M1.1101.1201.1501.02085.47M85.10M82.98M82.62M-17.60%-21.37%-40.12%-28.97%-65.20%-84.67%-18.90%--3.77%LossLoss11.61%Biotechnology
APLSApellis Pharmaceuticals
19.970-2.550-11.32%3.49M71.31M22.80022.52023.10019.7552.51B1.68B125.52M84.23M-17.72%-17.27%-20.25%-42.33%-25.12%-64.28%-37.42%--4.14%LossLoss14.85%Biotechnology

Comments

Read more